Biography of Cyril Konto
Last update: 20 days agoCareer
Cyril was Vice President, Clinical Development at Allogene Therapeutics, and Executive Director, Early Immuno-Oncology Clinical Development at Pfizer. Cyril Konto joined Ichnos Sciences in 2021. Cyril served as Chief Medical Officer at Ichnos Sciences.
Cyril Konto is currently Director, President and Chief Executive Officer at Ichnos Sciences - View - Ichnos Sciences org chart
Create your alert
to follow the career of Cyril Konto.
Education
In 2004, Cyril Konto completed a Doctor of Medicine in Medical Oncology at Université René Descartes (Paris V).
They have also studied at Université René Descartes (Paris V) :
Find more alumni from Université René Descartes (Paris V)
More about Cyril Konto
Do you need to know more about Cyril Konto? More results.
Participate
Social media
- Cyril Konto on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Cyril Konto
The colleagues of Cyril Konto
Company Colleagues
- At Ichnos Sciences, Cyril Konto has 15 colleagues including David Lubner (Director), Dennis Purcell (Director)…
Industry Colleagues
- In the Biotechnology industry, Cyril Konto has 30,266 colleagues in 2,283 companies located in 40 countries. 14,433 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Cyril Konto.
